Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,337 | 80 | 94.2% |
| Education | $144.99 | 2 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $452.27 | 7 | $0 (2023) |
| Teleflex LLC | $360.30 | 6 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $223.74 | 7 | $0 (2023) |
| Astellas Pharma US Inc | $204.75 | 6 | $0 (2022) |
| KARL STORZ Endoscopy-America | $165.67 | 4 | $0 (2020) |
| Medtronic USA, Inc. | $160.97 | 1 | $0 (2018) |
| Antares Pharma, Inc. | $108.63 | 6 | $0 (2024) |
| Myovant Sciences Inc. | $93.69 | 5 | $0 (2022) |
| Verity Pharmaceuticals Inc. | $91.94 | 5 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $82.75 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $195.10 | 11 | Endo USA, Inc. ($65.46) |
| 2023 | $470.99 | 18 | Teleflex LLC ($143.30) |
| 2022 | $462.29 | 17 | Boston Scientific Corporation ($133.43) |
| 2021 | $369.03 | 11 | Teleflex LLC ($167.16) |
| 2020 | $315.72 | 12 | KARL STORZ Endoscopy-America ($147.25) |
| 2019 | $382.48 | 9 | Boston Scientific Corporation ($134.80) |
| 2018 | $195.89 | 3 | Medtronic USA, Inc. ($160.97) |
| 2017 | $89.99 | 1 | Astellas Pharma US Inc ($89.99) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: UROLOGY | ||||||
| 10/30/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/24/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: UROLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/24/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/13/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $18.83 | General |
| Category: Prostate cancer | ||||||
| 06/03/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: ONCOLOGY | ||||||
| 05/29/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: UROLOGY | ||||||
| 01/31/2024 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Food and Beverage | Cash or cash equivalent | $21.80 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/08/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $24.16 | General |
| Category: Prostate cancer | ||||||
| 10/25/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/02/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Urology | ||||||
| 08/29/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: HORMONE THERAPY | ||||||
| 07/25/2023 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: UROLOGY | ||||||
| 07/05/2023 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: UROLOGY | ||||||
| 06/19/2023 | Supernus Pharmaceuticals, Inc. | TLANDO (Drug), XYOSTED | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/07/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ONCOLOGY | ||||||
| 05/31/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: ONCOLOGY | ||||||
| 05/17/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: ONCOLOGY | ||||||
| 05/01/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Urology | ||||||
| 04/12/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $17.58 | General |
| Category: Prostate cancer | ||||||
| 03/24/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: HORMONE THERAPY | ||||||
| 02/21/2023 | Boston Scientific Corporation | AMS 700 CXR RTE Kit (Device) | Food and Beverage | In-kind items and services | $43.83 | General |
| Category: AMS 700 CXR RTE Kit_URO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,982 | 38,871 | $696,842 | $169,507 |
| 2022 | 27 | 1,987 | 35,817 | $620,356 | $148,358 |
| 2021 | 22 | 1,756 | 4,427 | $556,670 | $111,083 |
| 2020 | 20 | 1,066 | 2,866 | $388,256 | $74,665 |
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3145 | Injection, testosterone undecanoate, 1 mg | Office | 2023 | 12 | 33,750 | $61,763 | $46,970 | 76.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 222 | 270 | $78,570 | $22,471 | 28.6% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 26 | 26 | $62,270 | $13,223 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 123 | 171 | $49,761 | $11,333 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $34,342 | $8,302 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 127 | 142 | $27,832 | $7,523 | 27.0% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 20 | 25 | $33,740 | $7,475 | 22.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 96 | 120 | $70,920 | $6,662 | 9.4% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 22 | 41 | $78,686 | $5,110 | 6.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 29 | 30 | $17,730 | $4,992 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 53 | 53 | $23,638 | $4,481 | 19.0% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 23 | 23 | $22,310 | $3,880 | 17.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 148 | 182 | $12,012 | $3,280 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 67 | 76 | $14,896 | $3,105 | 20.8% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 37 | 40 | $15,480 | $3,023 | 19.5% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 29 | 29 | $18,966 | $2,712 | 14.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 203 | 268 | $3,484 | $2,243 | 64.4% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 13 | 13 | $8,502 | $2,190 | 25.8% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 17 | 17 | $12,155 | $1,837 | 15.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $5,096 | $1,714 | 33.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 163 | 203 | $16,849 | $1,415 | 8.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 14 | 14 | $4,998 | $1,370 | 27.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $4,103 | $958.16 | 23.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 98 | $6,566 | $851.10 | 13.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 297 | 373 | $2,238 | $814.00 | 36.4% |
About Dr. Christopher Corder, MD
Dr. Christopher Corder, MD is a Surgery healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2012. The National Provider Identifier (NPI) number assigned to this provider is 1871857219.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Corder, MD has received a total of $2,481 in payments from pharmaceutical and medical device companies, with $195.10 received in 2024. These payments were reported across 82 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,337).
As a Medicare-enrolled provider, Corder has provided services to 6,791 Medicare beneficiaries, totaling 81,981 services with total Medicare billing of $503,613. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Other Specialties Urology
- Location Omaha, NE
- Active Since 06/29/2012
- Last Updated 06/29/2012
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1871857219
Products in Payments
- XIAFLEX (Biological) $267.59
- UROLIFT (Device) $193.14
- UroLift System (Device) $167.16
- INTERSTIM (Device) $160.97
- ORGOVYX (Drug) $142.26
- Solyx SIS System (Device) $133.43
- AMS (Device) $128.89
- CMOS VIDECYSTURETHROSCOPE US (Device) $128.59
- XYOSTED (Drug) $94.07
- Trelstar (Drug) $91.94
- GENERAL ERECTILE DYSFUNCTION (Device) $70.90
- XTANDI (Drug) $58.80
- CAMCEVI (Drug) $57.76
- KEYTRUDA (Biological) $51.72
- GENERAL - ERECTILE DYSFUNCTION (Device) $50.54
- BOTOX (Biological) $49.80
- NOCDURNA (Drug) $49.15
- AMS 700 CXR RTE Kit (Device) $43.83
- CMOS VIDEO URETEROSCOPE, 8.5 FR. X 675MM (Device) $37.08
- GEMTESA (Drug) $34.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Omaha
Edward Fehringer, Md, MD
Surgery — Payments: $2.4M
Zachary Bauman, D.o., M.h.a, D.O., M.H.A
Surgery — Payments: $321,486
Dr. Gary Anthone, M.d, M.D
Surgery — Payments: $210,312
Dmitry Oleynikov, Md, MD
Surgery — Payments: $197,892
David Vogel, Md, MD
Surgery — Payments: $46,369
Dr. Brad Winterstein, M.d, M.D
Surgery — Payments: $40,685